Robert (Bob) Saunders has been Managing Partner of Saunders Capital LLC from 1986-present as well as Saunders Murdoch & Associates LLC from 2010-present. Saunders was also Managing Director of Chrysalis Ventures Inc. from 1997-2009, and served as Senior Advisor 2009-2010. Saunders was Planning officer and Managing Director for Strategic Planning and Business Development at Providian Capital Management from 1993-1997. Saunders was Business Strategy Consultant at The Boston Consulting Group and Bain & Co. from 1978-1986. Saunders is a Founding board member of MetaCyte, the University of Louisville’s life science incubator and Chairman of the Board of the Enterprise Corp, the entrepreneurship affiliate of GLI, Louisville’s Chamber of Commerce.
Saunders is an active “Super Angel” investor via Saunders Capital and Saunders Murdoch in several health care startup companies including: Aptamera, MedVentures, US Worldmeds, Vivorte, NX Pharmagen, IF Technologies, Summit Biosciences, Appellis, Carrot Medical, Bioscale, Med City News, Mequillibrium, Cobra Stylet, Advanced Cancer Therapeutics (ACT), Key Health, and Advanced Imaging Concepts (via bCatalyst).
Saunders holds a Master degree from Harvard University, and the London School of Economics and an AB with Distinction from Stanford University. He was a Fulbright Scholar and a Marshall Scholar.
Board & Advisor Roles (1)Update